Procalcitonin Rapid Test for signs of sepsis
-
Where is the price?
Pricing is based on shipping location and the number of units ordered. To request a price, please use the Request a Quote button below. A sales representative will respond to you quickly.
Product Features
- Semi-quantitative Procalcitonin (PCT) rapid test
- Detects human procalcitonin in serum or plasma
- Point-of-care cassette format
- Includes reference card for estimating PCT concentration
- Results available in approximately 30 minutes
- Supports clinical assessment of bacterial infection and sepsis
- Designed for professional healthcare use
The Challenge: Early Recognition of Sepsis
Sepsis is one of the three leading causes of death and morbidity around the time of childbirth. Sepsis is defined as a multi-organ inflammatory response due to bacterial infection. The etiology of sepsis may be from an infection during pregnancy, from Group A strep, from an injury during childbirth or due to a range of factors after childbirth (called puerperal sepsis). Miscarriages, prolonged labor, mastitis, c-sections and other interventions that expose women to increased risk of infection may be associated with sepsis. Having rapid markers of sepsis is an important research and diagnostic tool for the women's health community and beyond.
THE SOLUTION
The Procalcitonin Rapid Test is a rapid and convenient antigen-capture immunochromatographic assay for the semi-quantitative detection of human procalcitonin (PCT) in serum or plasma at or above the level of 0.5 ng/ml. PCT concentrations are elevated in infection. Rising in response to a proinflammatory stimulus, PCT concentration is an important indicator of severity of the disease. It is intended for professional use as an aid in the diagnosis and controlling the treatment of severe bacterial infection and sepsis.
Procalcitonin testing can support clinical decision-making by helping healthcare professionals evaluate suspected bacterial infections alongside patient assessment, laboratory findings, and established clinical protocols. It is particularly valuable where rapid diagnostic information may improve timely intervention and referral.
Clinical Applications
The Procalcitonin Rapid Test is suitable for:
- Maternal and postpartum sepsis assessment
- Emergency departments
- Hospitals and maternity wards
- Intensive care settings
- Clinical laboratories
- Point-of-care testing
- Infection screening and monitoring
- Low-resource healthcare settings where rapid assessment is beneficial
To test, a sample of plasma or serum is added to the sample well of the test. The test works by detecting PCT in the plasma or serum sample as it flows through the assay by first PCT antibodies conjugated with colloidal gold that attach to the PCT and provide a “visual tag” for the antigen-antibody-colloidal gold complex and second, by a test zone with immobilized antibodies that capture the complex, the visual tags producing a visible pink-colored band that is confirmation of the presence of PCT. The color intensity of the band is proportionate to the PCT concentration of the sample and a reference card is given to estimate the concentration level. Results are ready in 30 minutes.
Frequently Asked Questions
What does the Procalcitonin Rapid Test detect?
The test detects human procalcitonin (PCT), a biomarker that may increase in response to severe bacterial infection and sepsis.
What sample type is required?
The test uses serum or plasma specimens.
How quickly are results available?
Results are typically available in approximately 30 minutes.
Who should use this test?
The Procalcitonin Rapid Test is intended for use by trained healthcare professionals as part of the clinical assessment of suspected bacterial infection and sepsis.
Can this test be used on its own to diagnose sepsis?
No. The test should be interpreted together with the patient's clinical presentation, medical history, and other laboratory findings to support diagnosis and treatment decisions.